By itself, measurement of GFR may not be sufficient for identifying stage 1 and stage 2 CKD, because in those patients the GFR may in fact be normal or borderline normal. In such cases, the presence of one or more of the following markers of kidney damage can establish the diagnosis [5...
PRESCRIBING INFORMATION MEDICAL INFO REQUEST FAQs PATIENT SITE Connect with Us 2025 Medicare Part D Updates: Encourage Your Patients to Enroll Learn more (English)Learn more (Spanish) Video Player For your adult patients with CKD associated with T2D ...
Among United States patients, obstacles to education include the complex nature of kidneydisease information, low baseline awareness, limited health literacy and numeracy, limited availability of CKD information,and lack of readiness to learn. For providers, lack of time and clinical confidence combine ...
IMPORTANT SAFETY INFORMATIONFOR FARXIGA Contraindications History of serious hypersensitivity reaction to dapagliflozin or any of the excipients in FARXIGA. Warnings and Precautions Ketoacidosis:FARXIGA significantly increases the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus. Type 2 ...
[1]Health Survey for England(2009).Volume1:Health and life styles.Published December 16,2010 on behalf of the NHS Information Centre.Retrieved from http://www.hscic.gov.uk/pubs/hse09report[J]. [2]JhaV,Garcia-GarciaG,IsekiK,etal.Chr...
IMPORTANT SAFETY INFORMATIONFOR FARXIGA Contraindications History of serious hypersensitivity reaction to dapagliflozin or any of the excipients in FARXIGA. Warnings and Precautions Ketoacidosis:FARXIGA significantly increases the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus. Type 2 ...
10. Heerspink HJL et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2020; 383(15):1436–46. 收录于合集#药闻速递 69个
◆ 该适应症的获批基于EMPA-KIDNEY临床试验。试验结果表明,在广泛的、有疾病进展风险的慢性肾病(CKD)患者中,与安慰剂组相比,恩格列净治疗可降低肾病进展或心血管死亡的相对风险28%,可降低因任何原因住院的相对风险14%,具有统计学意义(HR;0.86;95% CI0.78-0.95;P=0.0025 [绝对风险降低4.4%])。该试验显示总体安全...
IMPORTANT SAFETY INFORMATIONFOR FARXIGA Contraindications History of serious hypersensitivity reaction to dapagliflozin or any of the excipients in FARXIGA. Warnings and Precautions Ketoacidosis:FARXIGA significantly increases the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus. Type 2 ...
IMPORTANT SAFETY INFORMATIONFOR FARXIGA Contraindications History of serious hypersensitivity reaction to dapagliflozin or any of the excipients in FARXIGA. Warnings and Precautions Ketoacidosis:FARXIGA significantly increases the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus. Type 2 ...